Cardiovascular surgery in Turner syndrome - early outcome and long-term follow-up

Table 1 Baseline characteristics and medications (n = 51)

Characteristics	Number
Age at the first surgery at Mayo years	28 (8-41)
Height, cm	154 ± 31
Weight, kg	58 ± 20
Body surface area, m2	1.56 ± 0.46
Body mass index, kg/m2	27 ± 8
Comorbidities
Hypertension	26 (51%)
Hyperlipidemia	21 (42%)
Current or prior smoker	5 (10%)
Diabetes mellitus	9 (18%)
Sleep apnea	7 (14%)
Hypothyroidism	29 (57%)
Atrial fibrillation	7 (14%)
Coronary artery disease	9 (18%)
Prior stroke Medications	4 (8%)
Medications
Diuretics	12 (15%)
Beta and/or calcium channel blockers	28 (36%)
RAAS antagonist	26 (33%)
Warfarin	6 (6%)
Aspirin	37 (47%)
Statin	21 (27%)
Levothyroxine	27 (35%)
Estrogen	43 (55%)
Growth hormone (prior or current)	12 (25%)

RAAS: Renin angiotensin aldosterone system.